Guotou Securities: Rated Liaoning Yuelian Medical Technology Co., Ltd. as "Buy-A", with a target price of 161.52 yuan.

Guotou Securities research report pointed out that United Imaging Healthcare's product technology and research and development innovation capabilities are at a global leading position, comparable to top overseas manufacturers, which has laid a solid foundation for the company to compete globally. The company's technical level in various core areas is at the forefront internationally: in the field of magnetic resonance imaging, the company has the ability to independently design and develop high-field superconducting magnets, high-performance gradient coils, high-density RF coils, multi-channel distributed spectrometers, MR imaging software, and advanced applications. It has also launched the world's first 5.0T whole-body MRI system uMR Jupiter5T; in the field of CT, the company has research and production capabilities for detectors, tubes, high-voltage generators, high-speed rotating gantries, and advanced image processing applications; in molecular imaging, the company has core technologies such as detector development, electronics, reconstruction, and control. The company emphasizes the research and development of core components and independent controllability, and most of the core components of its product line are self-developed and self-produced. It is given a "Buy-A" investment rating with a target price of 161.52 yuan in six months.